FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3444411000001107: Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17286301000001111 Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
68737601000001117 Trasidrex modified-release tablets (Mercury Pharma Group Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Is a Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet false Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient Oxprenolol true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient Oxprenolol hydrochloride false Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient Cyclopenthiazide true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Is a Trasidrex true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Cyclopenthiazide true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Oxprenolol hydrochloride true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Is a Co-prenozide 160mg/0.25mg modified-release tablets false Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Is a Co-prenozide 160mg/0.25mg modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets Is pack of False Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier
Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Trasidrex modified-release tablets (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start